[1
]
From the Division of Nephrology (L.A.I., S.J.C., A.S.L.) and the Institute for Clinical
Research and Health Policy Studies (H.T.), Tufts Medical Center, Tufts Clinical and
Translational Science Institute, Tufts University (H.T.), the Section on Genetics
and Epidemiology, Joslin Diabetes Center (A.D.), and the Department of Medicine, Harvard
Medical School (A.D.) - all in Boston; the Renal-Electrolyte and Hypertension Division,
Perelman School of Medicine (N.D.E.), and the Departments of Biostatistics, Epidemiology,
and Informatics, Center for Clinical Epidemiology and Biostatistics (W.Y.), University
of Pennsylvania, Philadelphia; the Department of Epidemiology, Johns Hopkins Bloomberg
School of Public Health and the Welch Center for Prevention, Epidemiology, and Clinical
Research, Johns Hopkins Medical Institutions (J.C., D.W., Y.S., M.E.G., E.S., S.H.B.),
the Division of Nephrology, Department of Medicine, Johns Hopkins University School
of Medicine (D.C.C., M.E.G.), and the Department of Medicine, Division of Nephrology,
University of Maryland School of Medicine (R.K.) - all in Baltimore; the Kidney Health
Research Collaborative, San Francisco Veterans Affairs (VA) Medical Center and University
of California, San Francisco (M.M.E., M.G.S.), the Division of Nephrology, Department
of Medicine, San Francisco VA Health Care System and University of California, San
Francisco (M.M.E.), and the Department of Medicine, Priscilla Chan and Mark Zuckerberg
San Francisco General Hospital and University of California, San Francisco (N.R.P.)
- all in San Francisco; the Clinical Trial Unit, Centre Hospitalier Universitaire
Vaudois, Lausanne, Switzerland (M.F.); the Division of Biostatistics, Department of
Population Health Sciences, University of Utah Health, Salt Lake City (T.G.); the
Department of Clinical Chemistry and Pharmacology, Institute of Laboratory Medicine,
Lund University, Lund, Sweden (A.G.); the Faculty of Medicine, University of Iceland,
Reykjavik, and the Icelandic Heart Association, Kopavogur - both in Iceland (V.G.);
the Departments of Medicine and Epidemiology, University of Alabama at Birmingham,
Birmingham (O.M.G.); the Departments of Laboratory Medicine and Pathology (A.B.K.,
J.C.S.), Pediatrics (M.M.), and Medicine (M.M.), University of Minnesota, Minneapolis,
and the Division of Nephrology and Hypertension, Mayo Clinic, Rochester (A.D.R., V.E.T.)
- all in Minnesota; the Faculty of Medical Sciences, University Medical Center Groningen,
Groningen, the Netherlands (G.N.); the Chronic Kidney Disease Section, National Institute
of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Phoenix,
AZ (R.G.N.); the Department of Nephrology and Hypertension, Glickman Urological and
Kidney Institute, Cleveland Clinic, Cleveland (E.D.P.); Rush University Medical Center,
Chicago (R.R.); and Steno Diabetes Center Copenhagen and the Department of Clinical
Medicine, University of Copenhagen - both in Copenhagen (P.R.).